NIKKEI 225
37,929.73 -530.35 (-1.38%) HANG SENG
17,136.13 -65.14 (-0.38%) CRUDE OIL
82.62 -0.19 (-0.23%) GOLD FUTURES
2,330.70 -7.70 (-0.33%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,491.50 -2,120.45 (-3.96%)
Agilent Technologies, Inc. (0HAV.L)
| Previous close | 139.65 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 3,613 |
| Market cap | 433.46M |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | 0.33 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Agilent Receives Scientists' Choice Awards for Sustainability
SANTA CLARA, Calif., April 16, 2024--Agilent Technologies Inc. (NYSE: A) announces that it is the recipient of two 2023 Sustainability Scientists’ Choice awards — Sustainable Supplier of the Year and Sustainable Product of the Year. These awards recognize Agilent as a leader in the area of sustainability.
- Business Wire
Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
SANTA CLARA, Calif., April 15, 2024--Agilent Technologies Inc. (NYSE: A) today announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demonstrates that the assay meets the higher standards established by IVDR. It ensures the continued availability of this trusted qualitative assay to clinical geneticists and other healthcare professionals throughout the EU.
- Business Wire
Agilent Brings Great Science to Life at Analytica 2024
SANTA CLARA, Calif., April 04, 2024--Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows. Analytica, the premier international trade fair for laboratory technology, analysis, and biotechnology, is scheduled to take place from April 9 to 12 in Munich, Germany.
